Trial Profile
Phase III trial of ixekizumab in patients with rheumatoid arthritis.
Status:
Planning
Phase of Trial:
Phase III
Latest Information Update: 04 Jul 2011
Price :
$35
*
At a glance
- Drugs Ixekizumab (Primary)
- Indications Rheumatoid arthritis
- Focus Registrational; Therapeutic Use
- 04 Jul 2011 New trial record